中山康方生物医药有限公司

Therapeutic Antibody Generation and Assay Screening

   Therapeutic antibody generation service.   RIMMs like procedure.   Provide functional cellular assay screening.   Stable cell line for FACS.   Reliably produce high affinity antibodies quickly.   Generate hard-to-obtain antibodies.   Combine activating immune system and breaking immune tolerance using different sets of special reagents.   Use combined indirect ELISA and competitive ELISA for functional antibody screening.   Antibody/ antigen interaction.   Epitope binning/ mapping.   Antibody internalization screening.  

<img src="https://sourcing-media.hktdc.com/product/92a78dcde39d11ea883f06c82c63b760/a54c0b89e39d11ea883f06c82c63b760" class="fr-fic fr-dib" data-strproductmediaid="1944e5b4e39e11ea883f06c82c63b760" />

<ul>
    <li>Therapeutic antibody generation service.</li>
    <li>RIMMs like procedure.</li>
    <li>Provide functional cellular assay screening.</li>
    <li>Stable cell line for FACS.</li>
    <li>Reliably produce high affinity antibodies quickly.</li>
    <li>Generate hard-to-obtain antibodies.</li>
    <li>Combine activating immune system and breaking immune tolerance using different sets of special reagents.</li>
    <li>Use combined indirect ELISA and competitive ELISA for functional antibody screening.</li>
    <li>Antibody/ antigen interaction.</li>
    <li>Epitope binning/ mapping.</li>
    <li>Antibody internalization screening.</li>
</ul>

    中山康方生物医药有限公司（简称康方生物）是由4位在海外知名大企业的药物研发和生产部门有多年工作经验的资深行业带头人及企业领导者创立。康方生物致力 于创建国际一流的蛋白和抗体药物研发高新技术平台，结合对国外医药领域发展和市场的敏锐眼光，通过产品定制的方式为国内外制药企业提供技术外包服务，同时 与制药企业进行战略合作，创制具有自主知识产权的抗体及蛋白新药，为人类健康及疾病治疗提供更好的手段。

我的采购